Cargando…

Cardioprotective Mechanism of Leonurine against Myocardial Ischemia through a Liver–Cardiac Crosstalk Metabolomics Study

Leonurine has been shown to have excellent anti-myocardial ischemia effects. Our previous studies suggested that cardiac protection by leonurine during myocardial ischemia appeared to be inextricably linked to its regulation of the liver. At present, however, there are few mechanistic studies of leo...

Descripción completa

Detalles Bibliográficos
Autores principales: Rong, Weiwei, Li, Jiejia, Pan, Dingyi, Zhou, Qinbei, Zhang, Yexuan, Lu, Qianxing, Wang, Liyun, Wang, Andong, Zhu, Yizhun, Zhu, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599793/
https://www.ncbi.nlm.nih.gov/pubmed/36291721
http://dx.doi.org/10.3390/biom12101512
_version_ 1784816680853045248
author Rong, Weiwei
Li, Jiejia
Pan, Dingyi
Zhou, Qinbei
Zhang, Yexuan
Lu, Qianxing
Wang, Liyun
Wang, Andong
Zhu, Yizhun
Zhu, Qing
author_facet Rong, Weiwei
Li, Jiejia
Pan, Dingyi
Zhou, Qinbei
Zhang, Yexuan
Lu, Qianxing
Wang, Liyun
Wang, Andong
Zhu, Yizhun
Zhu, Qing
author_sort Rong, Weiwei
collection PubMed
description Leonurine has been shown to have excellent anti-myocardial ischemia effects. Our previous studies suggested that cardiac protection by leonurine during myocardial ischemia appeared to be inextricably linked to its regulation of the liver. At present, however, there are few mechanistic studies of leonurine and its regulation of hepatic metabolism against ischemic injury. In this study, a metabolomics approach was developed to give a global view of the metabolic profiles of the heart and liver during myocardial ischemia. Principal component analysis and orthogonal partial least squares discrimination analysis were applied to filter differential metabolites, and a debiased sparse partial correlation analysis was used to analyze the correlation of the differential metabolites between heart and liver. As a result, a total of thirty-one differential metabolites were identified, six in the myocardial tissue and twenty-five in the hepatic tissue, involving multiple metabolic pathways including glycine, serine and threonine, purine, fatty acid, and amino acid metabolic pathways. Correlation analysis revealed a net of these differential metabolites, suggesting an interaction between hepatic and myocardial metabolism. These results suggest that leonurine may reduce myocardial injury during myocardial ischemia by regulating the metabolism of glycine, serine and threonine, purine, fatty acids, and amino acids in the liver and heart.
format Online
Article
Text
id pubmed-9599793
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95997932022-10-27 Cardioprotective Mechanism of Leonurine against Myocardial Ischemia through a Liver–Cardiac Crosstalk Metabolomics Study Rong, Weiwei Li, Jiejia Pan, Dingyi Zhou, Qinbei Zhang, Yexuan Lu, Qianxing Wang, Liyun Wang, Andong Zhu, Yizhun Zhu, Qing Biomolecules Article Leonurine has been shown to have excellent anti-myocardial ischemia effects. Our previous studies suggested that cardiac protection by leonurine during myocardial ischemia appeared to be inextricably linked to its regulation of the liver. At present, however, there are few mechanistic studies of leonurine and its regulation of hepatic metabolism against ischemic injury. In this study, a metabolomics approach was developed to give a global view of the metabolic profiles of the heart and liver during myocardial ischemia. Principal component analysis and orthogonal partial least squares discrimination analysis were applied to filter differential metabolites, and a debiased sparse partial correlation analysis was used to analyze the correlation of the differential metabolites between heart and liver. As a result, a total of thirty-one differential metabolites were identified, six in the myocardial tissue and twenty-five in the hepatic tissue, involving multiple metabolic pathways including glycine, serine and threonine, purine, fatty acid, and amino acid metabolic pathways. Correlation analysis revealed a net of these differential metabolites, suggesting an interaction between hepatic and myocardial metabolism. These results suggest that leonurine may reduce myocardial injury during myocardial ischemia by regulating the metabolism of glycine, serine and threonine, purine, fatty acids, and amino acids in the liver and heart. MDPI 2022-10-19 /pmc/articles/PMC9599793/ /pubmed/36291721 http://dx.doi.org/10.3390/biom12101512 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Rong, Weiwei
Li, Jiejia
Pan, Dingyi
Zhou, Qinbei
Zhang, Yexuan
Lu, Qianxing
Wang, Liyun
Wang, Andong
Zhu, Yizhun
Zhu, Qing
Cardioprotective Mechanism of Leonurine against Myocardial Ischemia through a Liver–Cardiac Crosstalk Metabolomics Study
title Cardioprotective Mechanism of Leonurine against Myocardial Ischemia through a Liver–Cardiac Crosstalk Metabolomics Study
title_full Cardioprotective Mechanism of Leonurine against Myocardial Ischemia through a Liver–Cardiac Crosstalk Metabolomics Study
title_fullStr Cardioprotective Mechanism of Leonurine against Myocardial Ischemia through a Liver–Cardiac Crosstalk Metabolomics Study
title_full_unstemmed Cardioprotective Mechanism of Leonurine against Myocardial Ischemia through a Liver–Cardiac Crosstalk Metabolomics Study
title_short Cardioprotective Mechanism of Leonurine against Myocardial Ischemia through a Liver–Cardiac Crosstalk Metabolomics Study
title_sort cardioprotective mechanism of leonurine against myocardial ischemia through a liver–cardiac crosstalk metabolomics study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599793/
https://www.ncbi.nlm.nih.gov/pubmed/36291721
http://dx.doi.org/10.3390/biom12101512
work_keys_str_mv AT rongweiwei cardioprotectivemechanismofleonurineagainstmyocardialischemiathroughalivercardiaccrosstalkmetabolomicsstudy
AT lijiejia cardioprotectivemechanismofleonurineagainstmyocardialischemiathroughalivercardiaccrosstalkmetabolomicsstudy
AT pandingyi cardioprotectivemechanismofleonurineagainstmyocardialischemiathroughalivercardiaccrosstalkmetabolomicsstudy
AT zhouqinbei cardioprotectivemechanismofleonurineagainstmyocardialischemiathroughalivercardiaccrosstalkmetabolomicsstudy
AT zhangyexuan cardioprotectivemechanismofleonurineagainstmyocardialischemiathroughalivercardiaccrosstalkmetabolomicsstudy
AT luqianxing cardioprotectivemechanismofleonurineagainstmyocardialischemiathroughalivercardiaccrosstalkmetabolomicsstudy
AT wangliyun cardioprotectivemechanismofleonurineagainstmyocardialischemiathroughalivercardiaccrosstalkmetabolomicsstudy
AT wangandong cardioprotectivemechanismofleonurineagainstmyocardialischemiathroughalivercardiaccrosstalkmetabolomicsstudy
AT zhuyizhun cardioprotectivemechanismofleonurineagainstmyocardialischemiathroughalivercardiaccrosstalkmetabolomicsstudy
AT zhuqing cardioprotectivemechanismofleonurineagainstmyocardialischemiathroughalivercardiaccrosstalkmetabolomicsstudy